Total synthesis of new indolo[2,3-a]quinolizine alkaloids sempervirine type, potential pharmaceuticals
作者:Teodozja M. Lipińska
DOI:10.1016/j.tet.2006.03.085
日期:2006.6
the AB–DE synthons, has been obtained. The final stages: desulfuration, and formation of the C-ring via the Gribble method have led to the expected zwitterionic alkaloids. Model syntheses of the indolopyridocoline and its methoxy analogue from 2-acetylpyridine have been performed for investigation of the microwave-induced Fischer synthesis of sensitive indoles and for obtaining compounds for comparative
从5-乙酰基-3-甲硫基-1分五个步骤详细阐述了两个系列的新五环杂环[ g ]吲哚并[2,3- a ]喹诺嗪生物碱(改性的sempervirine具有广泛的活性)的全合成。,2,4-三嗪(得自简单的无环材料)。在两个关键步骤中:电子逆需求Diors–Alder反应与环烯胺反应的前体,以及随后的3-乙酰基-1-甲基硫代环烷基的费歇尔吲哚化反应[ c已经获得了AB-DE合成子]吡啶。最后阶段:脱硫和通过Gribble方法形成C环已导致预期的两性离子生物碱。已经进行了吲哚吡咯啉及其从2-乙酰基吡啶的甲氧基类似物的模型合成,以研究敏感的吲哚的微波诱导费歇尔合成,并获得用于光谱数据比较研究的化合物。
Microwave-induced solid-supported Fischer indolization, a key step in the total synthesis of the sempervirine type methoxy analogues
作者:Teodozja Lipińska
DOI:10.1016/j.tetlet.2004.10.008
日期:2004.11
A general protocol for the synthesis of 2-heteroaryl-5-methoxyindoles has been developed utilizing a microwave-induced solid-supported Fischer indolization under controlled conditions This route uses 2-acetylpyridine as a model and 3-acetyl derivatives of cycloalkeno[c]fused pyridines as the synthetic building blocks towards new 9-methoxyindolo[2,3-a]quinolizine alkaloids.
对于2 -杂芳基-5- methoxyindoles合成的一般协议已被开发利用在受控条件下微波诱导的固体负载的Fischer吲哚此路线使用2-乙酰基作为cycloalkeno的模型和3-乙酰基衍生物[ C ^ ]熔融吡啶作为合成原料,可阻止新的9-甲氧基吲哚并[2,3- a ]喹诺嗪生物碱。
Olefin Hydroarylation Catalyzed by (pyridyl-indolate)Pt(II) Complexes: Catalytic Efficiencies and Mechanistic Aspects
作者:Benjamin A. Suslick、Allegra L. Liberman-Martin、Truman C. Wambach、T. Don Tilley
DOI:10.1021/acscatal.7b01560
日期:2017.7.7
A series of Pt(II) complexes of the type (N–N)PtPh(SR2) (N–N = 2,2′-pyridyl-indolate) were prepared, and their performance as catalysts for the hydroarylation of olefins was assessed. Evidence that the catalysis is homogeneous and is Pt-mediated is provided by control experiments with added hindered base (2,6-di-tert-butyl-4-methylpyridine) and Hg(0). Two potential catalytic intermediates, (tBuPyInd)PtPh(C2H4)
制备了一系列(N–N)PtPh(SR 2)(N–N = 2,2'-吡啶基-吲哚酸酯)类型的Pt(II)配合物,并评估了它们作为烯烃加氢芳基化反应的催化剂的性能。 。对照实验提供了添加受阻碱(2,6-二叔丁基-4-甲基吡啶)和Hg(0)的证据,证明了催化是均相的并且是Pt介导的。两种潜在的催化中间体(t BuPyInd)PtPh(C 2 H 4)和(t BuPyInd)Pt(CH 2 CH 2 Ph)(C 2 H 4),合成,并探索其催化功效。此外,还确定了分解和失活途径,包括通过β-氢化物消除和配体还原性脱金属形成苯乙烯。
Tuning the Luminescence and Electroluminescence of Diphenylboron Complexes of 5-Substituted 2-(2‘-Pyridyl)indoles
作者:Qinde Liu、Maria S. Mudadu、Hartmut Schmider、Randolph Thummel、Ye Tao、Suning Wang
DOI:10.1021/om020446j
日期:2002.10.1
To examine the effect of substituent groups on the luminescence of BPh2(X-2-PI) complexes, three new air-stable boron complexes BPh2(F-2-PI) (5a), BPh2(Cl-2-PI) (5b), and BPh2(CH3O2-PI) (5c) were synthesized and characterized, where F-2-PI = 5-fluoro-2-(2'-pyridyl)indole, Cl-2-PI = 5-chloro-2-(2'-pyridyl)indole, and CH3O-2-PI = 5-methoxyl-2-(2'-pyridyl)indole. In these complexes, the 5-substituted 2-PI ligand chelates in a tretrahedral fashion to the boron center. Compounds 5a-c are luminescent, with 5a having the highest emission efficiency. Compared with the emission maximum of BPh2(2-PI) (516 nm), the emission maximum of 5a and 5b is blue-shifted to 490 and 487 nm, respectively, while the emission of 5c is red-shifted to 532 nm, indicating the possibility of tuning the luminescence of these complexes by varying the substituent groups on the 2-PI ligand. An electroluminescent device using compound 5a as the emitter and the electron transport material has been fabricated.
Pyrido[2,3-<i>a</i>]pyrrolo[3,4-<i>c</i>]carbazole-5,7(6<i>H</i>)-diones: Synthesis, Cyclometalation, and Protein Kinase Inhibition
作者:Eric Meggers、Howard Bregman、Douglas S. Williams
DOI:10.1055/s-2005-865331
日期:——
Synthetic routes to pyrido[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-diones are disclosed and examples for their subsequent transformations into cyclometalated protein kinase inhibitors are presented.